NALOXEGOL OXALATE

NALOXEGOL OXALATE was reported 3970 times

NALOXEGOL OXALATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MACULAR DYSTROPHY CONGENITAL 2 0.0645
1 DRUG SCREEN 2 0.0444
2 JUVENILE MYOCLONIC EPILEPSY 2 0.0317
3 LARYNGEAL OBSTRUCTION 5 0.0273
4 IMPLANT SITE DEHISCENCE 2 0.0233
5 DELUSION OF PARASITOSIS 3 0.0191
6 POST LAMINECTOMY SYNDROME 3 0.0174
7 HYPERTROPHY OF TONGUE PAPILLAE 2 0.0165
8 INFREQUENT BOWEL MOVEMENTS 35 0.0140
9 BLOOD BRAIN BARRIER DEFECT 2 0.0132
10 TOOTH SOCKET HAEMORRHAGE 3 0.0125
11 SPINAL CORD INJURY CERVICAL 3 0.0119
12 BOWEL MOVEMENT IRREGULARITY 86 0.0112
13 ANAPHYLACTOID SHOCK 5 0.0106
14 GASTROINTESTINAL HYPERMOTILITY 4 0.0093
15 PSEUDOSTROKE 3 0.0087
16 OPIATES POSITIVE 4 0.0083
17 INHIBITORY DRUG INTERACTION 11 0.0069
18 TISSUE INJURY 3 0.0069
19 DRUG SCREEN POSITIVE 54 0.0068
20 FEAR OF EATING 2 0.0065
21 YAWNING 17 0.0064
22 FAECAL VOLUME DECREASED 3 0.0063
23 COMPLEX REGIONAL PAIN SYNDROME 9 0.0061
24 GAIT SPASTIC 2 0.0058
25 ACCIDENT AT HOME 3 0.0058
26 INFECTIOUS COLITIS 3 0.0057
27 FAECES HARD 21 0.0054
28 OCCIPITAL NEURALGIA 3 0.0053
29 BLADDER PERFORATION 2 0.0052
30 CONGENITAL DIAPHRAGMATIC HERNIA 2 0.0051
31 GENITAL ABSCESS 2 0.0050
32 GASTROINTESTINAL MOTILITY DISORDER 25 0.0047
33 PILOERECTION 5 0.0046
34 INFUSION SITE SCAR 2 0.0045
35 DYSCHEZIA 13 0.0043
36 FAECALOMA 23 0.0042
37 LIMB ASYMMETRY 3 0.0039
38 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 4 0.0038
39 FAECAL VOMITING 2 0.0038
40 ABDOMINAL SYMPTOM 3 0.0037
41 CORNEAL EROSION 2 0.0037
42 INFUSION SITE BRUISING 8 0.0037
43 INFUSION SITE MASS 4 0.0037
44 SOFT TISSUE DISORDER 4 0.0036
45 CATAPLEXY 5 0.0035
46 BILE DUCT STENOSIS 4 0.0033
47 CATARACT SUBCAPSULAR 2 0.0033
48 MEDICAL DEVICE SITE INFECTION 2 0.0032
49 GASTROINTESTINAL HYPOMOTILITY 7 0.0031
50 INFUSION SITE URTICARIA 2 0.0030
51 CYST RUPTURE 2 0.0029
52 FUNCTIONAL GASTROINTESTINAL DISORDER 10 0.0029
53 DRUG SCREEN NEGATIVE 5 0.0028
54 CERVICAL RADICULOPATHY 2 0.0028
55 HYPERPARATHYROIDISM SECONDARY 7 0.0028
56 CARDIAC SEPTAL DEFECT 2 0.0028
57 LUMBAR RADICULOPATHY 3 0.0026
58 INTENTIONAL PRODUCT MISUSE 224 0.0026
59 GASTROINTESTINAL PAIN 28 0.0025
60 FUNGAEMIA 4 0.0025
61 BODY HEIGHT DECREASED 27 0.0025
62 ANORECTAL DISORDER 5 0.0025
63 RECTAL PROLAPSE 3 0.0025
64 WITHDRAWAL SYNDROME 102 0.0024
65 MITRAL VALVE PROLAPSE 4 0.0024
66 NEPHROGENIC ANAEMIA 11 0.0024
67 INFECTED BITE 2 0.0024
68 CANCER PAIN 6 0.0023
69 ENDOCRINE OPHTHALMOPATHY 2 0.0023
70 RADICULOPATHY 6 0.0023
71 HYPOVITAMINOSIS 3 0.0023
72 ABDOMINAL NEOPLASM 2 0.0022
73 RASH MORBILLIFORM 6 0.0022
74 INFUSION SITE HAEMORRHAGE 7 0.0021
75 SNORING 8 0.0021
76 ANAL INCONTINENCE 19 0.0021
77 LUMBAR SPINAL STENOSIS 6 0.0021
78 ADMINISTRATION SITE EXTRAVASATION 2 0.0020
79 IMMUNE-MEDIATED DERMATITIS 2 0.0020
80 INFUSION SITE DISCOMFORT 2 0.0019
81 CARPAL TUNNEL DECOMPRESSION 2 0.0019
82 JOINT CONTRACTURE 2 0.0019
83 BONE NEOPLASM 2 0.0019
84 KIDNEY ENLARGEMENT 2 0.0018
85 GASTRIC DILATATION 3 0.0018
86 CATHETER SITE DISCHARGE 2 0.0018
87 DRUG EFFECT VARIABLE 2 0.0018
88 DRUG WITHDRAWAL SYNDROME 155 0.0018
89 PRE-EXISTING CONDITION IMPROVED 11 0.0018
90 CONSTIPATION 384 0.0018
91 ARTERIAL HAEMORRHAGE 2 0.0017
92 PROCTALGIA 11 0.0017
93 HORMONE-REFRACTORY PROSTATE CANCER 2 0.0017
94 MAGNETIC RESONANCE IMAGING ABNORMAL 2 0.0017
95 FREQUENT BOWEL MOVEMENTS 45 0.0017
96 FLATULENCE 94 0.0017
97 EYELID SKIN DRYNESS 2 0.0016
98 INTERVERTEBRAL DISC DISORDER 7 0.0016
99 INFUSION SITE WARMTH 2 0.0016
100 CEREBROSPINAL FLUID LEAKAGE 3 0.0016
101 HOSPICE CARE 16 0.0016
102 SACROILIITIS 3 0.0016
103 ABNORMAL FAECES 13 0.0016
104 DEFAECATION URGENCY 11 0.0016
105 ADENOCARCINOMA PANCREAS 2 0.0016
106 PATIENT DISSATISFACTION WITH TREATMENT 3 0.0016
107 BLADDER DISORDER 15 0.0015
108 SPINAL COLUMN STENOSIS 7 0.0015
109 EYELID PAIN 3 0.0015
110 CLUSTER HEADACHE 2 0.0015
111 INFUSION SITE RASH 2 0.0015
112 AGRANULOCYTOSIS 27 0.0015
113 FORMICATION 10 0.0014
114 HYPERHIDROSIS 185 0.0014
115 WEIGHT FLUCTUATION 15 0.0014
116 GLUTEN SENSITIVITY 2 0.0014
117 INTENSIVE CARE 2 0.0014
118 BLOOD ELECTROLYTES DECREASED 2 0.0014
119 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
120 PULMONARY PAIN 4 0.0014
121 NECK INJURY 4 0.0014
122 SENSITIVE SKIN 10 0.0014
123 DRUG EFFECT DELAYED 6 0.0013
124 METASTASES TO MENINGES 3 0.0013
125 BREAKTHROUGH PAIN 3 0.0013
126 NECK SURGERY 3 0.0013
127 THERAPEUTIC PRODUCT EFFECT VARIABLE 5 0.0013
128 INFUSION SITE PRURITUS 4 0.0013
129 NERVE INJURY 14 0.0013
130 HEPATIC CYTOLYSIS 16 0.0013
131 ANTIPHOSPHOLIPID SYNDROME 2 0.0012
132 CYSTITIS INTERSTITIAL 2 0.0012
133 SPINAL FUSION SURGERY 5 0.0012
134 GASTROINTESTINAL SOUNDS ABNORMAL 6 0.0012
135 DEVICE INFUSION ISSUE 3 0.0012
136 INABILITY TO AFFORD MEDICATION 12 0.0012
137 PERSECUTORY DELUSION 3 0.0012
138 BACK INJURY 13 0.0012
139 INTERVERTEBRAL DISC DEGENERATION 11 0.0012
140 CLOSTRIDIAL INFECTION 4 0.0012
141 INADEQUATE ANALGESIA 10 0.0012
142 INSURANCE ISSUE 18 0.0012
143 IMPAIRED GASTRIC EMPTYING 16 0.0012
144 CARBOHYDRATE ANTIGEN 125 INCREASED 4 0.0012
145 LAZINESS 2 0.0012
146 SPINAL DISORDER 11 0.0012
147 MICTURITION DISORDER 4 0.0012
148 INFUSION SITE DISCHARGE 2 0.0011
149 SPINAL OPERATION 14 0.0011
150 ABDOMINAL PAIN 264 0.0011
151 ANIMAL BITE 3 0.0011
152 RETCHING 24 0.0011
153 INFUSION SITE SWELLING 7 0.0011
154 ABDOMINAL PAIN UPPER 229 0.0011
155 POST PROCEDURAL INFECTION 9 0.0011
156 ABDOMINAL RIGIDITY 3 0.0011
157 THERAPEUTIC PRODUCT EFFECT DELAYED 5 0.0011
158 CONTRAST MEDIA ALLERGY 2 0.0011
159 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
160 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 8 0.0011
161 ADRENAL DISORDER 2 0.0010
162 VOMITING PROJECTILE 3 0.0010
163 EARLY SATIETY 2 0.0010
164 AUTONOMIC NERVOUS SYSTEM IMBALANCE 3 0.0010
165 URINE ANALYSIS ABNORMAL 3 0.0010
166 MIXED LIVER INJURY 3 0.0010
167 REBOUND ACID HYPERSECRETION 3 0.0010
168 DYSPHORIA 5 0.0010
169 BACK DISORDER 16 0.0010
170 CHANGE OF BOWEL HABIT 2 0.0010
171 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 10 0.0010
172 COMPULSIVE SHOPPING 2 0.0010
173 CHILLS 113 0.0010
174 FAECES SOFT 7 0.0010
175 BREAST CANCER RECURRENT 3 0.0009
176 DRUG EFFECT INCREASED 3 0.0009
177 CATHETER SITE ERYTHEMA 2 0.0009
178 CHRONIC KIDNEY DISEASE 71 0.0009
179 END STAGE RENAL DISEASE 17 0.0009
180 METASTATIC NEOPLASM 4 0.0009
181 MUSCLE STRAIN 8 0.0009
182 BEHAVIOUR DISORDER 5 0.0009
183 MUSCLE SPASMS 169 0.0009
184 HEPATIC NEOPLASM 3 0.0009
185 DEAFNESS NEUROSENSORY 3 0.0009
186 OTITIS MEDIA 3 0.0009
187 INTESTINAL OBSTRUCTION 34 0.0009
188 LYME DISEASE 3 0.0009
189 MALNUTRITION 10 0.0009
190 SLEEP APNOEA SYNDROME 17 0.0009
191 IDIOPATHIC INTRACRANIAL HYPERTENSION 2 0.0009
192 FEEDING DISORDER 18 0.0009
193 RESTLESS LEGS SYNDROME 16 0.0009
194 HERNIA 17 0.0009
195 NERVE COMPRESSION 8 0.0009
196 LARGE INTESTINE POLYP 6 0.0009
197 HYPOPHAGIA 22 0.0009
198 IMPLANT SITE INFECTION 2 0.0009
199 STRESS CARDIOMYOPATHY 5 0.0009
200 NECROTISING FASCIITIS 3 0.0009
201 COLITIS MICROSCOPIC 4 0.0008
202 ISCHAEMIC STROKE 15 0.0008
203 GASTROINTESTINAL OBSTRUCTION 2 0.0008
204 INFUSION SITE ERYTHEMA 7 0.0008
205 SPONDYLITIS 3 0.0008
206 FOOD INTOLERANCE 3 0.0008
207 ABDOMINAL DISTENSION 85 0.0008
208 MUSCLE SPASTICITY 10 0.0008
209 CEREBRAL DISORDER 6 0.0008
210 BLOOD IMMUNOGLOBULIN G DECREASED 2 0.0008
211 HEART INJURY 2 0.0008
212 CHRONIC SINUSITIS 3 0.0008
213 SPINAL OSTEOARTHRITIS 7 0.0008
214 PARANASAL SINUS DISCOMFORT 3 0.0008
215 ABDOMINAL INFECTION 2 0.0008
216 INITIAL INSOMNIA 8 0.0008
217 OESOPHAGEAL DISORDER 3 0.0008
218 SEASONAL ALLERGY 11 0.0008
219 TEMPERATURE INTOLERANCE 8 0.0008
220 HYPERPROLACTINAEMIA 5 0.0008
221 MUSCLE RUPTURE 3 0.0008
222 SPINAL CORD COMPRESSION 3 0.0008
223 MULTIPLE ALLERGIES 6 0.0008
224 CLOSTRIDIUM DIFFICILE COLITIS 8 0.0008
225 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
226 ABDOMINAL MASS 2 0.0007
227 IRRITABLE BOWEL SYNDROME 16 0.0007
228 ANAESTHETIC COMPLICATION 2 0.0007
229 ENURESIS 3 0.0007
230 NEURALGIA 18 0.0007
231 PERIPHERAL VENOUS DISEASE 3 0.0007
232 HEAD INJURY 23 0.0007
233 MACULE 2 0.0007
234 LARGE INTESTINE PERFORATION 5 0.0007
235 ANAL HAEMORRHAGE 2 0.0007
236 KIDNEY INFECTION 14 0.0007
237 SKIN INFECTION 8 0.0007
238 LIGAMENT SPRAIN 7 0.0007
239 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
240 HEPATIC PAIN 3 0.0007
241 PULMONARY TUBERCULOSIS 3 0.0007
242 FIBROMYALGIA 17 0.0007
243 FIBULA FRACTURE 2 0.0007
244 DIVERTICULUM INTESTINAL 3 0.0007
245 BEDRIDDEN 9 0.0007
246 SPINAL PAIN 8 0.0007
247 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
248 SKIN HAEMORRHAGE 10 0.0007
249 CREPITATIONS 2 0.0007
250 HAEMORRHOIDS 13 0.0007
251 INCONTINENCE 7 0.0007
252 BONE MARROW DISORDER 2 0.0007
253 CRANIOCEREBRAL INJURY 2 0.0007
254 EATING DISORDER 14 0.0007
255 LUMBAR VERTEBRAL FRACTURE 3 0.0007
256 BLOOD PRESSURE ABNORMAL 13 0.0007
257 NERVOUSNESS 34 0.0007
258 MENISCUS INJURY 4 0.0006
259 SCOLIOSIS 4 0.0006
260 DIARRHOEA HAEMORRHAGIC 6 0.0006
261 FLANK PAIN 6 0.0006
262 TIBIA FRACTURE 3 0.0006
263 MUSCULOSKELETAL DISCOMFORT 11 0.0006
264 BLOOD SODIUM DECREASED 12 0.0006
265 ELECTROENCEPHALOGRAM ABNORMAL 2 0.0006
266 STEVENS-JOHNSON SYNDROME 14 0.0006
267 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
268 AUTOIMMUNE DISORDER 6 0.0006
269 RENAL TUBULAR NECROSIS 6 0.0006
270 PANCREATIC DISORDER 3 0.0006
271 LISTLESS 2 0.0006
272 RECTAL HAEMORRHAGE 26 0.0006
273 ABDOMINAL TENDERNESS 3 0.0006
274 GASTROINTESTINAL DISORDER 54 0.0006
275 FAECES DISCOLOURED 13 0.0006
276 BLOOD POTASSIUM DECREASED 18 0.0006
277 DIARRHOEA 386 0.0006
278 PAIN 367 0.0006
279 EMPHYSEMA 6 0.0006
280 PRODUCT ADMINISTRATION ERROR 12 0.0006
281 TASTE DISORDER 12 0.0006
282 PATHOLOGICAL FRACTURE 3 0.0006
283 TUBULOINTERSTITIAL NEPHRITIS 11 0.0006
284 WEIGHT LOSS POOR 3 0.0006
285 VITAMIN D DECREASED 5 0.0006
286 GASTROOESOPHAGEAL REFLUX DISEASE 47 0.0006
287 LEFT VENTRICULAR FAILURE 2 0.0006
288 CERVICAL VERTEBRAL FRACTURE 2 0.0006
289 NOCTURIA 7 0.0006
290 PARTIAL SEIZURES 3 0.0006
291 NECK PAIN 32 0.0006
292 BLOOD LACTIC ACID INCREASED 3 0.0006
293 GROIN PAIN 5 0.0006
294 GAIT INABILITY 19 0.0006
295 HALLUCINATION, VISUAL 12 0.0006
296 COLD SWEAT 10 0.0006
297 ABDOMINAL DISCOMFORT 95 0.0006
298 JAUNDICE CHOLESTATIC 2 0.0006
299 SCIATICA 9 0.0006
300 THERMAL BURN 4 0.0006
301 FOOD POISONING 3 0.0006
302 PARALYSIS 8 0.0006
303 ANAL ABSCESS 3 0.0006
304 PRODUCT RESIDUE PRESENT 3 0.0006
305 FACIAL BONES FRACTURE 2 0.0006
306 APPARENT DEATH 2 0.0006
307 BONE LESION 2 0.0006
308 UPPER LIMB FRACTURE 11 0.0006
309 OESOPHAGITIS 6 0.0005
310 DEVICE KINK 2 0.0005
311 NONSPECIFIC REACTION 3 0.0005
312 DEAFNESS UNILATERAL 3 0.0005
313 OSTEOARTHRITIS 23 0.0005
314 OVARIAN CANCER 5 0.0005
315 DIVERTICULITIS 15 0.0005
316 HIATUS HERNIA 7 0.0005
317 URINARY RETENTION 18 0.0005
318 HEART RATE ABNORMAL 3 0.0005
319 RIB FRACTURE 11 0.0005
320 PERONEAL NERVE PALSY 3 0.0005
321 DERMATITIS CONTACT 6 0.0005
322 MICTURITION URGENCY 6 0.0005
323 INTERNAL HAEMORRHAGE 6 0.0005
324 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 5 0.0005
325 GASTRIC INFECTION 2 0.0005
326 PROCEDURAL COMPLICATION 4 0.0005
327 ELECTROLYTE IMBALANCE 6 0.0005
328 SKIN WARM 3 0.0005
329 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 4 0.0005
330 HYPOVOLAEMIA 3 0.0005
331 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 17 0.0005
332 INTERVERTEBRAL DISC PROTRUSION 11 0.0005
333 ACCIDENT 6 0.0005
334 OBESITY 8 0.0005
335 MUSCLE RIGIDITY 6 0.0005
336 NEPHROLITHIASIS 23 0.0005
337 COLITIS 19 0.0005
338 CARPAL TUNNEL SYNDROME 7 0.0005
339 SPINAL FRACTURE 10 0.0005
340 RHINITIS 4 0.0005
341 RHINORRHOEA 32 0.0005
342 PRODUCT USE ISSUE 93 0.0005
343 RASH MACULO-PAPULAR 11 0.0005
344 GALLBLADDER OPERATION 2 0.0005
345 INGUINAL HERNIA 3 0.0005
346 DECUBITUS ULCER 4 0.0005
347 DYSURIA 18 0.0005
348 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
349 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
350 SPINAL COMPRESSION FRACTURE 4 0.0005
351 PRODUCT AVAILABILITY ISSUE 11 0.0005
352 THINKING ABNORMAL 9 0.0005
353 MIGRAINE 46 0.0005
354 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 23 0.0005
355 FEELING ABNORMAL 114 0.0005
356 THERAPEUTIC RESPONSE CHANGED 3 0.0005
357 JOINT DISLOCATION 5 0.0005
358 RENAL PAIN 5 0.0005
359 CYSTITIS 15 0.0005
360 WHITE BLOOD CELL COUNT ABNORMAL 3 0.0005
361 HEPATITIS 12 0.0005
362 POST PROCEDURAL COMPLICATION 9 0.0005
363 GASTRIC DISORDER 16 0.0005
364 DRUG DOSE OMISSION 77 0.0005
365 INFUSION SITE PAIN 6 0.0005
366 TREMOR 77 0.0005
367 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 3 0.0005
368 BACK PAIN 107 0.0005
369 BONE CANCER 2 0.0005
370 SKIN LACERATION 5 0.0005
371 URINE OUTPUT DECREASED 4 0.0005
372 DYSPHEMIA 2 0.0005
373 IMMUNE SYSTEM DISORDER 6 0.0005
374 INTENTIONAL DEVICE MISUSE 2 0.0005
375 GINGIVAL SWELLING 2 0.0005
376 LIGAMENT RUPTURE 2 0.0005
377 APPETITE DISORDER 3 0.0005
378 IRRITABILITY 27 0.0004
379 ILEUS PARALYTIC 2 0.0004
380 QUALITY OF LIFE DECREASED 6 0.0004
381 VOMITING 210 0.0004
382 GASTROINTESTINAL INFECTION 4 0.0004
383 MENINGITIS ASEPTIC 2 0.0004
384 BRONCHIECTASIS 3 0.0004
385 ARTHRITIS 35 0.0004
386 COLITIS ISCHAEMIC 3 0.0004
387 ULCER 7 0.0004
388 HAEMOGLOBIN INCREASED 2 0.0004
389 PERIPHERAL COLDNESS 6 0.0004
390 PNEUMONIA BACTERIAL 4 0.0004
391 ABDOMINAL PAIN LOWER 11 0.0004
392 LYMPHOEDEMA 3 0.0004
393 IRON DEFICIENCY ANAEMIA 4 0.0004
394 PROCEDURAL PAIN 12 0.0004
395 ARTHROPATHY 24 0.0004
396 FEELING COLD 12 0.0004
397 SEXUAL DYSFUNCTION 5 0.0004
398 DISCOMFORT 26 0.0004
399 LEUKAEMIA 4 0.0004
400 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 22 0.0004
401 BLOOD IRON DECREASED 5 0.0004
402 PRODUCT SUPPLY ISSUE 3 0.0004
403 NAUSEA 332 0.0004
404 ENDOMETRIOSIS 2 0.0004
405 MYOCLONUS 5 0.0004
406 POLYNEUROPATHY 5 0.0004
407 IMPAIRED QUALITY OF LIFE 6 0.0004
408 CHOLESTASIS 8 0.0004
409 BALANCE DISORDER 36 0.0004
410 CANDIDA INFECTION 7 0.0004
411 HEMIPARESIS 7 0.0004
412 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
413 HALLUCINATION 31 0.0004
414 INCORRECT DOSAGE ADMINISTERED 2 0.0004
415 SCAR 7 0.0004
416 RENAL FAILURE 54 0.0004
417 KNEE OPERATION 4 0.0004
418 PSYCHIATRIC SYMPTOM 3 0.0004
419 HYPOPHOSPHATAEMIA 3 0.0004
420 LIMB INJURY 11 0.0004
421 ARTHROPOD BITE 3 0.0004
422 DISORIENTATION 16 0.0004
423 ILEUS 5 0.0004
424 ANEURYSM 2 0.0004
425 MALAISE 176 0.0004
426 FLUID INTAKE REDUCED 2 0.0004
427 BRAIN INJURY 4 0.0004
428 PRODUCT DOSE OMISSION 26 0.0004
429 MUSCLE ATROPHY 5 0.0004
430 ANXIETY 112 0.0004
431 TOOTH ABSCESS 4 0.0004
432 THERAPY CESSATION 20 0.0004
433 THYROID DISORDER 6 0.0004
434 CACHEXIA 2 0.0004
435 FALL 129 0.0004
436 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
437 SKIN ULCER 10 0.0004
438 POOR VENOUS ACCESS 4 0.0004
439 POLLAKIURIA 16 0.0004
440 GASTROINTESTINAL INFLAMMATION 3 0.0004
441 ADVERSE EVENT 35 0.0004
442 ILLNESS 39 0.0004
443 FULL BLOOD COUNT ABNORMAL 4 0.0004
444 BLOOD ALBUMIN DECREASED 3 0.0004
445 ADVERSE REACTION 5 0.0004
446 DYSSTASIA 11 0.0004
447 INTENTIONAL PRODUCT USE ISSUE 33 0.0004
448 WEIGHT DECREASED 105 0.0004
449 EAR INFECTION 10 0.0004
450 HYPOTHYROIDISM 12 0.0004
451 JOINT INJURY 8 0.0004
452 HEREDITARY ANGIOEDEMA 4 0.0004
453 NIGHT SWEATS 12 0.0004
454 URINARY INCONTINENCE 11 0.0004
455 MUSCLE DISORDER 3 0.0004
456 ERYTHEMA OF EYELID 2 0.0004
457 SLEEP DISORDER 26 0.0004
458 DEHYDRATION 49 0.0004
459 HYDROCEPHALUS 2 0.0004
460 GLAUCOMA 7 0.0004
461 INTESTINAL ISCHAEMIA 2 0.0004
462 HAEMATOCHEZIA 20 0.0004
463 ERUCTATION 7 0.0004
464 DECREASED APPETITE 84 0.0004
465 GASTRIC ULCER HAEMORRHAGE 2 0.0004
466 INJECTION SITE INJURY 2 0.0004
467 HEMIPLEGIA 3 0.0004
468 ORAL DISCOMFORT 5 0.0004
469 CONFUSIONAL STATE 58 0.0004
470 CHOKING 7 0.0004
471 ROAD TRAFFIC ACCIDENT 15 0.0004
472 INTESTINAL PERFORATION 4 0.0004
473 HAEMATEMESIS 9 0.0004
474 ACTIVITIES OF DAILY LIVING IMPAIRED 7 0.0004
475 DRUG INTERACTION 56 0.0004
476 SCAB 4 0.0004
477 BLOOD MAGNESIUM DECREASED 3 0.0003
478 HYPERTHYROIDISM 5 0.0003
479 POST PROCEDURAL HAEMORRHAGE 4 0.0003
480 MEMORY IMPAIRMENT 47 0.0003
481 GASTRITIS 9 0.0003
482 INFLUENZA 38 0.0003
483 HYPERCHLORHYDRIA 2 0.0003
484 DECREASED INTEREST 2 0.0003
485 BRADYKINESIA 2 0.0003
486 COVID-19 PNEUMONIA 4 0.0003
487 BRONCHITIS 25 0.0003
488 PERIPHERAL SWELLING 52 0.0003
489 DRUG EFFECT LESS THAN EXPECTED 5 0.0003
490 MOBILITY DECREASED 24 0.0003
491 STAPHYLOCOCCAL INFECTION 11 0.0003
492 ASTHENIA 125 0.0003
493 OSTEOMYELITIS 6 0.0003
494 LACRIMATION INCREASED 10 0.0003
495 PELVIC PAIN 6 0.0003
496 OSTEOPENIA 5 0.0003
497 AGITATION 24 0.0003
498 BRAIN NEOPLASM 3 0.0003
499 UROSEPSIS 3 0.0003
500 SMALL INTESTINAL OBSTRUCTION 4 0.0003
501 TENDON RUPTURE 4 0.0003
502 ANKLE FRACTURE 5 0.0003
503 CHOLANGITIS 2 0.0003
504 THERAPY INTERRUPTED 23 0.0003
505 BLOOD CHOLESTEROL INCREASED 15 0.0003
506 BACTERIAL INFECTION 6 0.0003
507 ACUTE KIDNEY INJURY 49 0.0003
508 SECRETION DISCHARGE 4 0.0003
509 BRAIN FOG 5 0.0003
510 HOT FLUSH 24 0.0003
511 PRODUCT USE COMPLAINT 5 0.0003
512 INTENTIONAL DOSE OMISSION 9 0.0003
513 PNEUMOTHORAX 5 0.0003
514 OFF LABEL USE 275 0.0003
515 HYPOXIA 11 0.0003
516 SEROTONIN SYNDROME 6 0.0003
517 ROTATOR CUFF SYNDROME 4 0.0003
518 MOVEMENT DISORDER 10 0.0003
519 PANCREATITIS ACUTE 7 0.0003
520 HAEMOGLOBIN ABNORMAL 2 0.0003
521 URINARY TRACT INFECTION 53 0.0003
522 HYPERCHOLESTEROLAEMIA 3 0.0003
523 CHROMATURIA 7 0.0003
524 PRESCRIBED OVERDOSE 6 0.0003
525 HEART RATE IRREGULAR 7 0.0003
526 CARDIAC FLUTTER 2 0.0003
527 INCOHERENT 2 0.0003
528 MUSCLE TIGHTNESS 5 0.0003
529 EAR PAIN 6 0.0003
530 BONE PAIN 18 0.0003
531 INFLAMMATORY BOWEL DISEASE 3 0.0003
532 COELIAC DISEASE 3 0.0003
533 VITREOUS FLOATERS 3 0.0003
534 DYSPEPSIA 30 0.0003
535 ORAL CANDIDIASIS 4 0.0003
536 DYSGRAPHIA 2 0.0003
537 TOOTH INFECTION 4 0.0003
538 DISABILITY 6 0.0003
539 UPPER RESPIRATORY TRACT INFECTION 14 0.0003
540 SOMNOLENCE 61 0.0003
541 DRUG EFFECT INCOMPLETE 11 0.0003
542 BLISTER 17 0.0003
543 CRYING 11 0.0003
544 HYPOACUSIS 13 0.0003
545 PANIC ATTACK 11 0.0003
546 ADVERSE DRUG REACTION 27 0.0003
547 RESTLESSNESS 11 0.0003
548 INSOMNIA 80 0.0003
549 FUNGAL INFECTION 10 0.0003
550 PNEUMONIA 97 0.0003
551 HEADACHE 187 0.0003
552 BREAST MASS 2 0.0003
553 EXTRA DOSE ADMINISTERED 12 0.0003
554 DRY MOUTH 24 0.0003
555 NEUROPATHY PERIPHERAL 28 0.0003
556 SLUGGISHNESS 3 0.0003
557 HYPOAESTHESIA 44 0.0003
558 ABNORMAL LOSS OF WEIGHT 2 0.0003
559 EAR DISCOMFORT 3 0.0003
560 DYSPNOEA EXERTIONAL 11 0.0003
561 LIMB DISCOMFORT 9 0.0003
562 CONTUSION 28 0.0003
563 MUSCULAR WEAKNESS 33 0.0003
564 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
565 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
566 EYE DISCHARGE 3 0.0003
567 HYPERTRANSAMINASAEMIA 2 0.0003
568 PRODUCT USE IN UNAPPROVED INDICATION 71 0.0003
569 HOSPITALISATION 44 0.0003
570 DERMATITIS 6 0.0003
571 WOUND 8 0.0003
572 DRUG INEFFECTIVE 377 0.0003
573 WEIGHT INCREASED 64 0.0003
574 BURNING SENSATION 20 0.0003
575 ENCEPHALOPATHY 7 0.0003
576 KNEE ARTHROPLASTY 6 0.0003
577 DYSPHAGIA 27 0.0003
578 SCRATCH 3 0.0003
579 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
580 SINUSITIS 29 0.0003
581 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
582 HAND FRACTURE 2 0.0003
583 LOSS OF CONSCIOUSNESS 36 0.0003
584 PNEUMONIA ASPIRATION 7 0.0003
585 GALLBLADDER DISORDER 5 0.0003
586 DRUG EFFECT DECREASED 15 0.0003
587 PARAESTHESIA ORAL 4 0.0003
588 GAIT DISTURBANCE 53 0.0003
589 DEPRESSION 63 0.0003
590 OEDEMA 15 0.0003
591 TOOTHACHE 5 0.0003
592 PRODUCT PRESCRIBING ISSUE 6 0.0003
593 MAJOR DEPRESSION 2 0.0003
594 PRODUCTIVE COUGH 13 0.0003
595 DENTAL CARIES 3 0.0003
596 FOOT DEFORMITY 3 0.0003
597 RENAL INJURY 8 0.0003
598 PANCYTOPENIA 15 0.0003
599 ORAL PAIN 6 0.0003
600 SNEEZING 6 0.0003
601 MUSCULOSKELETAL PAIN 14 0.0003
602 BLOOD CALCIUM DECREASED 3 0.0003
603 ANGER 9 0.0003
604 UNEVALUABLE EVENT 20 0.0003
605 CONTRAINDICATED PRODUCT ADMINISTERED 8 0.0003
606 FRACTURE 5 0.0003
607 BLOOD COUNT ABNORMAL 4 0.0003
608 BLOOD URINE PRESENT 5 0.0003
609 CHOLECYSTECTOMY 3 0.0003
610 HEART RATE INCREASED 26 0.0003
611 FEELING JITTERY 5 0.0003
612 HYPERTHERMIA 2 0.0003
613 INCREASED APPETITE 5 0.0003
614 THROMBOSIS 21 0.0003
615 LIPASE INCREASED 2 0.0003
616 GASTRIC HAEMORRHAGE 3 0.0003
617 MUSCLE TWITCHING 6 0.0003
618 LOWER LIMB FRACTURE 5 0.0003
619 ACUTE RESPIRATORY FAILURE 5 0.0003
620 DISTURBANCE IN ATTENTION 14 0.0003
621 FOOD ALLERGY 2 0.0003
622 DRUG INTOLERANCE 25 0.0003
623 CONCUSSION 2 0.0003
624 PAIN IN EXTREMITY 76 0.0003
625 RENAL DISORDER 12 0.0003
626 NERVOUS SYSTEM DISORDER 8 0.0003
627 BACTERAEMIA 3 0.0003
628 FURUNCLE 2 0.0003
629 GINGIVAL PAIN 2 0.0003
630 HYPERLIPIDAEMIA 3 0.0003
631 BLOOD DISORDER 2 0.0002
632 THYROID CANCER 3 0.0002
633 CYTOKINE RELEASE SYNDROME 5 0.0002
634 HIP FRACTURE 8 0.0002
635 TARDIVE DYSKINESIA 7 0.0002
636 FRUSTRATION TOLERANCE DECREASED 2 0.0002
637 DYSKINESIA 10 0.0002
638 OSTEOPOROSIS 10 0.0002
639 SEIZURE 28 0.0002
640 CYST 3 0.0002
641 VIRAL INFECTION 8 0.0002
642 FATIGUE 187 0.0002
643 TINNITUS 11 0.0002
644 BLOOD UREA INCREASED 4 0.0002
645 CELLULITIS 12 0.0002
646 LABORATORY TEST ABNORMAL 7 0.0002
647 TRANSIENT ISCHAEMIC ATTACK 8 0.0002
648 ATRIAL FIBRILLATION 23 0.0002
649 SWELLING 22 0.0002
650 POOR QUALITY SLEEP 5 0.0002
651 HAEMATOMA 6 0.0002
652 NIGHTMARE 8 0.0002
653 DIPLOPIA 6 0.0002
654 HYSTERECTOMY 2 0.0002
655 ASTHMA 26 0.0002
656 NODULE 3 0.0002
657 ORTHOSTATIC HYPOTENSION 4 0.0002
658 MYALGIA 39 0.0002
659 RASH MACULAR 8 0.0002
660 ANHEDONIA 6 0.0002
661 COVID-19 40 0.0002
662 HEART RATE DECREASED 8 0.0002
663 PULMONARY CONGESTION 3 0.0002
664 DEPRESSED MOOD 12 0.0002
665 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
666 DYSPNOEA 128 0.0002
667 BLOOD PRESSURE DECREASED 15 0.0002
668 TOOTH DISORDER 5 0.0002
669 NEOPLASM MALIGNANT 15 0.0002
670 FACIAL PAIN 2 0.0002
671 JOINT RANGE OF MOTION DECREASED 3 0.0002
672 FEAR 6 0.0002
673 SINUS CONGESTION 3 0.0002
674 LIP DRY 2 0.0002
675 HAEMORRHAGE 23 0.0002
676 MOOD ALTERED 6 0.0002
677 MOOD SWINGS 7 0.0002
678 BONE DISORDER 4 0.0002
679 EXOSTOSIS 2 0.0002
680 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
681 DEATH 188 0.0002
682 MENTAL STATUS CHANGES 6 0.0002
683 AMNESIA 14 0.0002
684 COORDINATION ABNORMAL 3 0.0002
685 EYE SWELLING 8 0.0002
686 MALIGNANT NEOPLASM PROGRESSION 22 0.0002
687 APPENDICITIS 2 0.0002
688 PAIN IN JAW 6 0.0002
689 NASOPHARYNGITIS 39 0.0002
690 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
691 FOOT FRACTURE 4 0.0002
692 PRODUCT DOSE OMISSION ISSUE 62 0.0002
693 HYPERSOMNIA 6 0.0002
694 PULMONARY FIBROSIS 4 0.0002
695 DIZZINESS 104 0.0002
696 PANCREATIC CARCINOMA 6 0.0002
697 GENERAL PHYSICAL HEALTH DETERIORATION 24 0.0002
698 LOCALISED INFECTION 5 0.0002
699 HYPOKINESIA 3 0.0002
700 SEPSIS 23 0.0002
701 APATHY 3 0.0002
702 HYPERTENSION 43 0.0002
703 RHEUMATOID ARTHRITIS 23 0.0002
704 WHEEZING 12 0.0002
705 SINUS DISORDER 4 0.0002
706 CATARACT 12 0.0002
707 PULMONARY MASS 3 0.0002
708 NEOPLASM PROGRESSION 7 0.0002
709 THROAT IRRITATION 9 0.0002
710 AGEUSIA 5 0.0002
711 DRY EYE 10 0.0002
712 THERAPY NON-RESPONDER 9 0.0002
713 DEEP VEIN THROMBOSIS 13 0.0002
714 SWELLING FACE 13 0.0002
715 HYPOAESTHESIA ORAL 3 0.0002
716 APHASIA 6 0.0002
717 FULL BLOOD COUNT DECREASED 4 0.0002
718 PLEURAL EFFUSION 12 0.0002
719 DEVICE FAILURE 3 0.0002
720 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 14 0.0002
721 DIABETES MELLITUS 15 0.0002
722 HIP ARTHROPLASTY 3 0.0002
723 SKIN DISCOLOURATION 9 0.0002
724 FEELING HOT 12 0.0002
725 DRUG ADMINISTRATION ERROR 6 0.0002
726 HYPONATRAEMIA 11 0.0002
727 HELICOBACTER INFECTION 2 0.0002
728 INFLUENZA LIKE ILLNESS 16 0.0002
729 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 35 0.0002
730 LYMPHOMA 3 0.0002
731 GYNAECOMASTIA 6 0.0002
732 MUSCULOSKELETAL CHEST PAIN 3 0.0002
733 HYPERBILIRUBINAEMIA 2 0.0002
734 ARTHRALGIA 80 0.0002
735 SWOLLEN TONGUE 6 0.0002
736 RESPIRATORY TRACT INFECTION 5 0.0002
737 PANCREATITIS 10 0.0002
738 CHEST PAIN 35 0.0002
739 RESPIRATORY TRACT CONGESTION 3 0.0002
740 SURGERY 11 0.0002
741 BREAST PAIN 2 0.0002
742 IMPAIRED WORK ABILITY 4 0.0002
743 INFECTION 27 0.0002
744 BREAST CANCER METASTATIC 2 0.0002
745 CHEST DISCOMFORT 19 0.0002
746 DECREASED ACTIVITY 2 0.0002
747 HAEMOGLOBIN DECREASED 19 0.0002
748 BIPOLAR DISORDER 2 0.0002
749 MENTAL DISORDER 8 0.0002
750 LUNG DISORDER 9 0.0002
751 BLOOD PRESSURE INCREASED 28 0.0002
752 OSTEONECROSIS 6 0.0002
753 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 37 0.0002
754 JOINT SWELLING 22 0.0002
755 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 10 0.0002
756 PYREXIA 63 0.0002
757 COUGH 51 0.0002
758 MELAENA 4 0.0002
759 INJECTION SITE NODULE 2 0.0002
760 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
761 ABNORMAL DREAMS 5 0.0002
762 ILL-DEFINED DISORDER 11 0.0002
763 VISUAL ACUITY REDUCED 6 0.0002
764 EXPIRED PRODUCT ADMINISTERED 6 0.0002
765 VERTIGO 11 0.0002
766 EYE PAIN 10 0.0002
767 EYE INFECTION 2 0.0002
768 FLUID RETENTION 9 0.0002
769 CIRCULATORY COLLAPSE 3 0.0002
770 HEPATIC ENZYME INCREASED 12 0.0002
771 IMPAIRED DRIVING ABILITY 2 0.0002
772 MULTIPLE SCLEROSIS RELAPSE 12 0.0002
773 HERPES ZOSTER 10 0.0002
774 EPISTAXIS 13 0.0002
775 DELIRIUM 6 0.0002
776 OROPHARYNGEAL PAIN 16 0.0002
777 PSORIATIC ARTHROPATHY 7 0.0002
778 SPEECH DISORDER 9 0.0002
779 PARAESTHESIA 27 0.0002
780 NASAL CONGESTION 10 0.0002
781 HEAD DISCOMFORT 3 0.0002
782 NEUTROPENIA 23 0.0002
783 DISEASE PROGRESSION 20 0.0002
784 PRODUCT PRESCRIBING ERROR 4 0.0002
785 THIRST 3 0.0002
786 MULTIPLE SCLEROSIS 8 0.0002
787 RESPIRATORY DISORDER 5 0.0002
788 BLOOD PRESSURE FLUCTUATION 4 0.0002
789 GASTROENTERITIS VIRAL 3 0.0002
790 RASH PRURITIC 9 0.0002
791 LEUKOCYTOSIS 3 0.0002
792 RASH 72 0.0002
793 PRESYNCOPE 4 0.0002
794 CONDITION AGGRAVATED 50 0.0002
795 CYTOPENIA 2 0.0002
796 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
797 PALPITATIONS 19 0.0002
798 HYPERCALCAEMIA 2 0.0002
799 CARDIAC FAILURE CONGESTIVE 13 0.0002
800 DYSGEUSIA 12 0.0002
801 VISUAL IMPAIRMENT 20 0.0002
802 SEPTIC SHOCK 7 0.0002
803 MIDDLE INSOMNIA 3 0.0002
804 CARDIAC DISORDER 15 0.0002
805 GLYCOSYLATED HAEMOGLOBIN INCREASED 4 0.0002
806 BRAIN OEDEMA 2 0.0002
807 CARDIOVASCULAR DISORDER 4 0.0002
808 ANAEMIA 30 0.0002
809 WHITE BLOOD CELL COUNT INCREASED 6 0.0002
810 OEDEMA PERIPHERAL 19 0.0002
811 ERECTILE DYSFUNCTION 4 0.0002
812 INFLAMMATION 8 0.0002
813 DYSTONIA 3 0.0002
814 DYSPHONIA 9 0.0002
815 DEAFNESS 4 0.0002
816 SUICIDAL IDEATION 14 0.0002
817 MUCOSAL INFLAMMATION 4 0.0002
818 HAEMATOCRIT DECREASED 3 0.0002
819 LIP SWELLING 5 0.0001
820 SYNCOPE 15 0.0001
821 MALIGNANT MELANOMA 2 0.0001
822 PRODUCT PHYSICAL ISSUE 3 0.0001
823 TYPE 2 DIABETES MELLITUS 5 0.0001
824 PULMONARY EMBOLISM 14 0.0001
825 INJURY ASSOCIATED WITH DEVICE 3 0.0001
826 BODY TEMPERATURE INCREASED 3 0.0001
827 PALLOR 4 0.0001
828 ALANINE AMINOTRANSFERASE INCREASED 9 0.0001
829 GINGIVAL BLEEDING 2 0.0001
830 TREATMENT NONCOMPLIANCE 8 0.0001
831 PRODUCT PREPARATION ERROR 3 0.0001
832 LUNG NEOPLASM MALIGNANT 6 0.0001
833 CORONARY ARTERY OCCLUSION 2 0.0001
834 SKIN LESION 4 0.0001
835 RESPIRATORY DISTRESS 4 0.0001
836 PERITONITIS 3 0.0001
837 TREATMENT FAILURE 12 0.0001
838 HYPOMAGNESAEMIA 2 0.0001
839 HUNGER 2 0.0001
840 APHONIA 2 0.0001
841 MASS 2 0.0001
842 RENAL IMPAIRMENT 12 0.0001
843 BLOOD TEST ABNORMAL 2 0.0001
844 DEVICE OCCLUSION 2 0.0001
845 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
846 BLINDNESS UNILATERAL 2 0.0001
847 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
848 BRONCHOSPASM 2 0.0001
849 HYPERSENSITIVITY 26 0.0001
850 RED BLOOD CELL COUNT DECREASED 4 0.0001
851 CEREBRAL HAEMORRHAGE 5 0.0001
852 ANGINA PECTORIS 4 0.0001
853 PRODUCT SUBSTITUTION ISSUE 8 0.0001
854 ALOPECIA 27 0.0001
855 URTICARIA 23 0.0001
856 INJECTION SITE PRURITUS 9 0.0001
857 PULMONARY OEDEMA 6 0.0001
858 HAEMORRHAGE INTRACRANIAL 2 0.0001
859 EMOTIONAL DISTRESS 16 0.0001
860 ECONOMIC PROBLEM 2 0.0001
861 STOMATITIS 8 0.0001
862 HYPOKALAEMIA 6 0.0001
863 WHITE BLOOD CELL COUNT DECREASED 14 0.0001
864 BLOOD GLUCOSE INCREASED 24 0.0001
865 INJECTION SITE BRUISING 10 0.0001
866 OXYGEN SATURATION DECREASED 7 0.0001
867 VISION BLURRED 17 0.0001
868 MENTAL IMPAIRMENT 3 0.0001
869 RESPIRATORY FAILURE 9 0.0001
870 EYE IRRITATION 7 0.0001
871 BLOOD ALKALINE PHOSPHATASE INCREASED 3 0.0001
872 SKIN DISORDER 4 0.0001
873 AGGRESSION 6 0.0001
874 HYPOTENSION 24 0.0001
875 INJECTION SITE REACTION 8 0.0001
876 UNRESPONSIVE TO STIMULI 3 0.0001
877 DEVICE DEFECTIVE 2 0.0001
878 SEDATION 3 0.0001
879 MUSCULOSKELETAL STIFFNESS 10 0.0001
880 EOSINOPHILIA 2 0.0001
881 HYPERKALAEMIA 4 0.0001
882 DEVICE MALFUNCTION 8 0.0001
883 LYMPHOCYTE COUNT DECREASED 2 0.0001
884 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
885 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
886 LIVER DISORDER 5 0.0001
887 TACHYCARDIA 10 0.0001
888 DEVICE ISSUE 10 0.0001
889 THROAT TIGHTNESS 3 0.0001
890 PNEUMONITIS 3 0.0001
891 LOWER RESPIRATORY TRACT INFECTION 5 0.0001
892 HYPERGLYCAEMIA 4 0.0001
893 CARDIAC ARREST 9 0.0001
894 MYOCARDIAL INFARCTION 19 0.0001
895 RESPIRATORY ARREST 3 0.0001
896 BLOOD GLUCOSE ABNORMAL 2 0.0001
897 HAEMOPTYSIS 3 0.0001
898 HEPATIC STEATOSIS 2 0.0001
899 DEMENTIA 3 0.0001
900 COGNITIVE DISORDER 5 0.0001
901 HEPATIC CIRRHOSIS 2 0.0001
902 DYSARTHRIA 4 0.0001
903 OCULAR HYPERAEMIA 5 0.0001
904 GASTRIC ULCER 2 0.0001
905 BLOOD GLUCOSE DECREASED 5 0.0001
906 PRURITUS 40 0.0001
907 PLATELET COUNT DECREASED 11 0.0001
908 NEEDLE ISSUE 3 0.0001
909 PLASMA CELL MYELOMA 4 0.0001
910 PSYCHOTIC DISORDER 3 0.0001
911 ABNORMAL BEHAVIOUR 4 0.0001
912 INJECTION SITE HAEMORRHAGE 8 0.0001
913 FLUSHING 10 0.0001
914 BLINDNESS 4 0.0001
915 NEUTROPHIL COUNT DECREASED 4 0.0001
916 CARDIO-RESPIRATORY ARREST 4 0.0001
917 BRADYCARDIA 5 0.0001
918 LIVER FUNCTION TEST INCREASED 2 0.0001
919 ERYTHEMA 19 0.0001
920 ALTERED STATE OF CONSCIOUSNESS 2 0.0001
921 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
922 BLOOD CREATININE INCREASED 6 0.0001
923 IMPAIRED HEALING 3 0.0001
924 INFUSION RELATED REACTION 6 0.0001
925 MEDICATION ERROR 5 0.0001
926 GLOSSODYNIA 2 0.0001
927 EYE PRURITUS 3 0.0001
928 ACCIDENTAL EXPOSURE TO PRODUCT 9 0.0001
929 LETHARGY 5 0.0001
930 LYMPHADENOPATHY 3 0.0001
931 SYSTEMIC LUPUS ERYTHEMATOSUS 3 0.0001
932 ARRHYTHMIA 4 0.0001
933 PSORIASIS 11 0.0001
934 COMA 4 0.0001
935 PRODUCT ADHESION ISSUE 3 0.0001
936 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
937 CEREBROVASCULAR ACCIDENT 14 0.0001
938 HYPOGLYCAEMIA 4 0.0001
939 THERAPEUTIC RESPONSE DECREASED 5 0.0001
940 UNDERDOSE 6 0.0001
941 ACCIDENTAL OVERDOSE 3 0.0001
942 PRODUCT QUALITY ISSUE 11 0.0001
943 ABASIA 2 0.0001
944 EXPOSURE VIA SKIN CONTACT 2 0.0001
945 JOINT STIFFNESS 2 0.0001
946 DERMATITIS ATOPIC 4 0.0001
947 CARDIAC FAILURE 6 0.0001
948 BLOOD BILIRUBIN INCREASED 2 0.0001
949 RHABDOMYOLYSIS 3 0.0001
950 SKIN EXFOLIATION 6 0.0001
951 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
952 DEVICE LEAKAGE 3 0.0001
953 DEVICE DISLOCATION 3 0.0001
954 INJECTION SITE PAIN 21 0.0001
955 ASCITES 2 0.0001
956 ANGIOEDEMA 3 0.0001
957 DRY SKIN 9 0.0001
958 HEPATIC FAILURE 2 0.0001
959 SUICIDE ATTEMPT 4 0.0001
960 EMOTIONAL DISORDER 2 0.0001
961 INJECTION SITE ERYTHEMA 8 0.0001
962 BREAST CANCER 6 0.0001
963 BONE DENSITY DECREASED 2 0.0001
964 RASH ERYTHEMATOUS 3 0.0001
965 THROMBOCYTOPENIA 7 0.0001
966 INTENTIONAL OVERDOSE 4 0.0001
967 DRUG DEPENDENCE 10 0.0001
968 INCORRECT DOSE ADMINISTERED 14 0.0001
969 EYE DISORDER 2 0.0001
970 DEVICE DIFFICULT TO USE 4 0.0001
971 FEBRILE NEUTROPENIA 4 0.0001
972 LEUKOPENIA 3 0.0001
973 PRODUCT STORAGE ERROR 5 0.0001
974 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
975 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
976 C-REACTIVE PROTEIN INCREASED 2 0.0001
977 ANAPHYLACTIC REACTION 3 0.0001
978 INJECTION SITE MASS 2 0.0001
979 OVERDOSE 11 0.0001
980 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
981 DEVICE BREAKAGE 2 0.0000
982 COLITIS ULCERATIVE 2 0.0000
983 DISEASE RECURRENCE 2 0.0000
984 SKIN BURNING SENSATION 3 0.0000
985 INJECTION SITE SWELLING 3 0.0000
986 ECZEMA 2 0.0000
987 DRUG ABUSE 3 0.0000
988 BLADDER CANCER 2 0.0000
989 NO ADVERSE EVENT 6 0.0000
990 INJURY 2 0.0000
991 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
992 DRUG DOSE OMISSION BY DEVICE 2 0.0000